90 patents
Page 4 of 5
Utility
Anti-NGF Antibodies and Methods Thereof
15 Jul 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 4 Mar 21
Utility
Anti-NGF Antibodies and Methods Thereof
15 Jul 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 4 Mar 21
Utility
Recombinant Herpesvirus of Turkey Vectors Expressing Antigens of Avian Pathogens and Uses Thereof
1 Jul 21
The invention relates to recombinant viral vectors for the insertion and expression of foreign genes for use in safe immunizations to protect against a variety of pathogens.
Sing RONG, Yugang LUO, Tyler BROWN
Filed: 10 Sep 20
Utility
Anti-NGF Antibodies and Methods Thereof
1 Jul 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 10 Mar 21
Utility
Rotors for Immunoassays
1 Jul 21
The present invention provides an analyte detection system for detecting target analytes in a sample.
Rajesh K. Mehra, Kenneth P. Aron
Filed: 8 Mar 21
Utility
Anti-NGF Antibodies and Methods Thereof
24 Jun 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 9 Mar 21
Utility
Oil-based Adjuvants
10 Jun 21
The instant invention provides various formulations comprising combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or analogs thereof in oil emulsions, use thereof in preparations of immunogenic compositions and vaccines, and use thereof in the treatment of animals.
Paul Joseph Dominowski, Dennis L. Foss, Guillermo Gallo, John Morgan Hardham, Richard Lee Krebs, Sandra Ann Marie Lightle, Suman Mahan, Sangita Mediratta, Kaori Mohr, Duncan Mwangi, Sharath K. Rai, Sarah A. Salmon, Shaunak Vora, Lauren Wilmes
Filed: 16 Feb 21
Utility
Peptides and Methods for the Detection of Lyme Disease Antibodies
13 May 21
The invention provides compositions (e.g., peptide compositions) useful for the detection of antibodies that bind to Borrelia antigens.
Rajesh K. MEHRA, Kenneth P. Aron, Dennis M. Bleile, Jeremy Walker, Cristina Cuesico
Filed: 14 Jan 21
Utility
Method and a System for Quantitative or Qualitative Determination of a Target Component
4 Mar 21
A method and a system for quantitative or qualitative determination of a target component in a liquid sample.
Bent Overby, Niels Kristian Bau-Madsen, Martin Bak Heller
Filed: 5 Nov 20
Utility
Vaccines Against Hendra and Nipah Virus Infection
14 Jan 21
Disclosed is a method of protecting an animal in need thereof from Hendra or Nipah virus infection comprising administering to said animal a single dose of a vaccine, the vaccine comprising:an antigen component comprising a Hendra antigen or a Nipah antigen; and an adjuvant comprising oil, polycationic carrier and a CpG containing immunostimulatory oligonucleotide, wherein the vaccine is a W/O emulsion.
Paul Joseph Dominowski, Duncan M. Mwangi, Dennis Lee Foss, Sharath K. Rai, John Morgan Hardham
Filed: 18 Dec 18
Utility
Antimicrobial Peptides and Methods of Using Same
9 Dec 20
Antimicrobial peptides of general formula X0X1X2C X3X4X5CX6X7X8X9CYX10X11CX12X13 are provided.
Michael Kuhn, Christopher A. Zook, Derek James Sheehan, Eric Baima, Richard Andrew Ewin, Hilary Phelps
Filed: 4 Dec 18
Utility
Pcv/mycoplasma Hyopneumoniae Vaccine
28 Oct 20
This invention provides a combination vaccine which includes a porcine circovirus type 2 (PCV2) antigen and a cell free Mycoplasma hyopneumoniae (M.hyo) culture supernatant for protecting a pig against PCV2 and M.hyo infections, wherein the M.hyo culture supernatant is substantially free of PCV2 antibodies.
Gregory P. Nitzel, Jeffrey E. Galvin, John Keith Garrett, James R. Kulawik, II, Tracy L. Ricker, Megan Marie Smutzer
Filed: 27 Apr 20
Utility
Heterocyclic Compounds and Their Use for Treatment of Helminthic Infections and Diseases
28 Oct 20
Natalie Hawryluk, Stacie S. Canan, Kevin R. Condroski, Graham Kyne, Matthew Bedore, Sanjay Menon
Filed: 23 Apr 20
Utility
Mycoplasma Hyopneumoniae Vaccine
21 Oct 20
This invention provides a Mycoplasma hyopneumoniae (M.hyo) antigen that is compatible with antigens from other swine pathogens, wherein the M.hyo antigen is a cell free M.hyo culture supernatant which is substantially free of swine IgG.
Jeffrey E. Galvin, Gregory P. Nitzel, John Keith Garrett, James R. Kulawik, II, Tracy L. Ricker, Megan Marie Smutzer
Filed: 26 Apr 20
Utility
Methods Of Vaccine Administration
7 Oct 20
This invention relates to a method of treating a dog for canine diseases comprising administering to the dog therapeutically effective amounts of a vaccine, wherein the vaccine comprises viral antigens, a bacterin, or both, and wherein the vaccine is administered subcutaneously or orally according to the schedules provided herein.
Cassius McAllister Tucker, John David Haworth
Filed: 23 Jun 20
Utility
Method for Obtaining Information About a Farm Animal
23 Sep 20
The invention relates to a method for obtaining information about a farm animal, wherein a device (a) is attached to the head region of an animal, said device containing at least one acceleration sensor by means of which recurring acceleration data is measured, wherein the acceleration data is evaluated using automatic data processing means, and, as an outcome of the evaluation, is indicative of the activities and/or conditions of the animal.
Wolfgang AUER
Filed: 8 Jun 20
Utility
Endoparasitic Depsipeptides
9 Sep 20
Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christoper S. Knauer, Rajendran Vairagoundar
Filed: 27 Nov 18
Utility
Effective Vaccination Against Porcine Reproductive and Respiratory Syndrome (PRRS) Virus Prior to Weaning
8 Jul 20
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory Calvert, Robert G. Ankenbauer, Jacqueline Gayle Marx, Douglas S. Pearce, Marcia L. Keith
Filed: 17 Mar 20
Utility
Light Controlling Assembly for an Egg Identification System, and Associated Method
1 Jul 20
An egg identification system for determining viability of an avian egg is provided.
William Dongwook Suh, Joel James Walukas
Filed: 5 Mar 20
Utility
North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof
24 Jun 20
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory Calvert, David Ewell Slade, Siao-Kun W. Welch
Filed: 3 Mar 20